Heterogeneous expression of GAGE, NY-ESO-1, MAGE-A and SSX proteins in esophageal cancer: Implications for immunotherapy-Reference-Cited by-同舟云学术

Heterogeneous expression of GAGE, NY-ESO-1, MAGE-A and SSX proteins in esophageal cancer: Implications for immunotherapy

Published:2005 Issue:1 Volume:118 Page:123-128
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Akcakanat Argun,Kanda Tatsuo,Tanabe Tadashi,Komukai Shintarou,Yajima Kazuhito,Nakagawa Satoru,Ohashi Manabu,Hatakeyama Katsuyoshi

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference24 articles.

1. The Japanese Society for Esophageal Diseases. Comprehensive registry of esophageal cancer in Japan (1998, 1999) and long-term results of esophagectomy in Japan (1988-1997), 3rd ed., 2002. 33-48.

2. Treatment Outcomes of Resected Esophageal Cancer

3. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

4. NY-ESO-1 expression and its serum immunoreactivity in esophageal cancer

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A panel of cancer testis antigens in pan squamous cell carcinomas: implication for biomarkers and therapeutic targets;2024-05-23

2. Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers;Frontiers in Immunology;2023-06-16

3. NY-ESO-1 expression in solid tumors predicts prognosis;Medicine;2019-11

4. Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy;Journal of Cancer Research and Clinical Oncology;2019-01-17

5. Overexpression of cancer‐testis antigen melanoma‐associated antigen A1 in lung cancer: A novel biomarker for prognosis, and a possible target for immunotherapy;Journal of Cellular Physiology;2018-12-19